Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

zerohedge.com - Tyler Durden - Why 'Big Pharma' Will Never Make A Cheap Anti-Aging Drug
Why 'Big Pharma' Will Never Make A Cheap Anti-Aging Drug
Zero Hedge

For years, scientists have hypothesized that safe, cheap, generic drugs like metformin and rapamycin could slow aging, based on promising findings in animal models. But despite the evidenced hope, little has been done to see if these drugs actually…

indianexpress.com - Express News Service - CBI arrests Karnataka pharma firm MD in bribery case; seizes cash, gold
CBI arrests Karnataka pharma firm MD in bribery case; seizes cash, gold
The Indian Express

3 min read Bengaluru Make us preferred source on Google The Central Bureau of Investigation (CBI) on Thursday arrested Anurag Danayak, the managing director of state-owned Karnataka Antibiotics and Pharmaceuticals Limited (KAPL), for allegedly…

foreignpolicyjournal.com - David Prior - Jim Cramer Urges Investors To Sell Oracle (NYSE: ORCL) And Shun Liquor Stocks, Favoring Banks, Pharma, And Semiconductors
Jim Cramer Urges Investors To Sell Oracle (NYSE: ORCL) And Shun Liquor Stocks, Favoring Banks, Pharma, And Semiconductors
Foreign Policy Journal

Cramer delivered a pointed message to investors during the member Q&A segment on the July 17th episode of CNBC Mad Money Investing Club, outlining what to sell and where to rotate. His core advice was direct: dump Oracle (NYSE: ORCL), stay away…

thehindubusinessline.com - Indian pharma sector set for steady growth in FY27 on domestic demand: Report
Indian pharma sector set for steady growth in FY27 on domestic demand: Report
BusinessLine

The Indian pharmaceutical sector is expected to maintain a healthy growth trajectory in the coming quarters, supported by sustained domestic demand, a recovery in Contract Development and Manufacturing Organization/ Active Pharmaceutical Ingredient…

newswire.ca - Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
CNW

Issued on behalf of Helus Pharma™ Eli Lilly's agreement to acquire AtaiBeckley for up to $3.8 billion hands psychedelic medicine its first large-cap validation, and it lands on a late-stage cohort already carrying pivotal data into the back…

marketbeat.com - Avalyn Pharma (NASDAQ:AVLN) Shares Up 5.3% - Here's Why
Avalyn Pharma (NASDAQ:AVLN) Shares Up 5.3% - Here's Why
MarketBeat

Shares of Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) traded up 5.3% during mid-day trading on Friday. The company traded as high as $27.76 and last traded at $27.04. 63,435 shares changed hands during trading, a decline of 84% from the…

marketbeat.com - Ascendis Pharma A/S (NASDAQ:ASND) Stock Rating Lowered by Wall Street Zen
Ascendis Pharma A/S (NASDAQ:ASND) Stock Rating Lowered by Wall Street Zen
MarketBeat

Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a 'buy' rating to a 'hold' rating in a report issued on Saturday. Can BioMarin Stock Live Up to Wall Street's High…

marketbeat.com - Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month High - Here's Why
Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month High - Here's Why
MarketBeat

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report)'s stock price reached a new 52-week high on Friday. The stock traded as high as $59.31 and last traded at $59.3330, with a volume of 347128 shares trading hands. The stock had previously closed at…

barchart.com - Jim Van Meerten - Short Sellers Are Betting Against UroGen Pharma Stock, But Wall Street Expects 263% Earnings Growth in 2027
Short Sellers Are Betting Against UroGen Pharma Stock, But Wall Street Expects 263% Earnings Growth in 2027
Barchart.com

UroGen Pharma (URGN) has surged nearly 180% over the past year and has strong technical momentum. URGN maintains a 100% “Buy” technical opinion from Barchart. The company's revenue is projected to more than double this year and grow…

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume Increase - Here's What Happened
Ascentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume Increase - Here's What Happened
MarketBeat

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) saw an uptick in trading volume on Friday. Approximately 9,615 shares changed hands during mid-day trading, an increase of 38% from the previous session's volume…

cnbc.com - Elsa Ohlen - Fat cat? Weight-loss drugs may be coming for your overweight pet
Fat cat? Weight-loss drugs may be coming for your overweight pet
CNBC

Two U.S. biotech companies are testing experimental GLP-1 weight-loss treatments for overweight cats. It marks one of the earliest attempts to bring the blockbuster drug class into pet medicine. Analysts say the idea of GLP-1s for animals fits into…

thehindu.com - Ameer Shahul - Review of Manish Sabharwal and Sundeep Khanna's Made in India
Review of Manish Sabharwal and Sundeep Khanna's Made in India
The Hindu

Some stories deserve to be told because they capture the growth of an industry and the aspirations of a nation. Made in India: The Story of Desh Bandhu Gupta, Lupin and Indian Pharma is one such story. Elegantly written and rich in detail, it…

rediff.com - Nandita Malik - Indian Stock Market Surges: Sensex Jumps 965 Points on Blue-Chip, IT, Banking Rally
Indian Stock Market Surges: Sensex Jumps 965 Points on Blue-Chip, IT, Banking Rally
Rediff.com

Indian stock markets experienced a robust surge, with the Sensex jumping 964.58 points and the Nifty crossing the 24,330 mark, fuelled by strong buying in blue-chip, IT, and banking stocks amidst positive Q1 earnings expectations and a strategic…

seekingalpha.com - SA Transcripts - Vimian Group AB (publ) (VIMGF) Q2 2026 Earnings Call Transcript
Vimian Group AB (publ) (VIMGF) Q2 2026 Earnings Call Transcript
Seeking Alpha

Vimian Group AB (publ) (VIMGF) Q2 2026 Earnings Call July 17, 2026 3:00 AM EDT Alireza Tajbakhsh - Chief Executive Officer Carl Johan Boudrie - Deputy CEO, CFO & Interim Head of Specialty Pharma Kavya Deshpande - UBS Investment Bank, Research…

forbes.com - AllBusiness - The AI Company Transforming Medication Adherence And Weight Loss
The AI Company Transforming Medication Adherence And Weight Loss
Forbes

AI can now remotely monitor medication adherence and weight to generate trusted data. Medication adherence remains one of the healthcare industry's greatest challenges, impacting clinical trials, commercial therapies, and patient outcomes across…

Receive a Daily briefing on Pharma Industry News

Get Started